Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Human monoclonal antibody against human interleukin 13

EU orphan designation number: EU/3/13/1205   
Active ingredient: Human monoclonal antibody against human interleukin 13
Indication: Treatment of eosinophilic oesophagitis
Sponsor: Novartis Europharm Limited
Wimblehurst Road, Horsham, West Sussex RH12 5AB, United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
15/11/2013 Centralised Orphan - Designation EMA/OD/118/13 (2013)8052 of 13/11/2013